These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 21644077

  • 1. [Experimental oral candidiasis in healthy and immunocompromised BALB/c mice].
    Karaman M, Kiray M, Bayrakal V, Bağrıyanık HA, Yılmaz O, Bahar IH.
    Mikrobiyol Bul; 2011 Apr; 45(2):336-43. PubMed ID: 21644077
    [Abstract] [Full Text] [Related]

  • 2. Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats.
    Martinez A, Regadera J, Jimenez E, Santos I, Gargallo-Viola D.
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1008-13. PubMed ID: 11257009
    [Abstract] [Full Text] [Related]

  • 3. Gastrointestinal colonisation and systemic spread of Candida albicans in mice treated with antibiotics and prednisolone.
    Kobayashi-Sakamoto M, Tamai R, Isogai E, Kiyoura Y.
    Microb Pathog; 2018 Apr; 117():191-199. PubMed ID: 29477742
    [Abstract] [Full Text] [Related]

  • 4. Candida glabrata and Candida albicans; dissimilar tissue tropism and infectivity in a gnotobiotic model of mucosal candidiasis.
    Westwater C, Schofield DA, Nicholas PJ, Paulling EE, Balish E.
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):134-9. PubMed ID: 17854475
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
    Samaranayake YH, Wu PC, Samaranayake LP, Ho PL.
    J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
    [Abstract] [Full Text] [Related]

  • 10. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H, Tanimoto T, Taniai M, Taniguchi M, Ariyasu T, Arai S, Ohta T, Fukuda S.
    In Vivo; 2007 Dec; 21(1):25-32. PubMed ID: 17354610
    [Abstract] [Full Text] [Related]

  • 11. [Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects].
    Hernández-Solís SE, Rueda-Gordillo F, Rojas-Herrera RA.
    Rev Iberoam Micol; 2014 Dec; 31(2):137-40. PubMed ID: 24071641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
    Hayama K, Ishibashi H, Ishijima SA, Niimi K, Tansho S, Ono Y, Monk BC, Holmes AR, Harding DR, Cannon RD, Abe S.
    FEMS Microbiol Lett; 2012 Mar; 328(2):130-7. PubMed ID: 22211961
    [Abstract] [Full Text] [Related]

  • 18. Variation in biofilm formation among blood and oral isolates of Candida albicans and Candida dubliniensis.
    Villar-Vidal M, Marcos-Arias C, Eraso E, Quindós G.
    Enferm Infecc Microbiol Clin; 2011 Nov; 29(9):660-5. PubMed ID: 21899928
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.